Jon Kuwahara
Equibles does not estimate personal net worth.
Get an email with a short summary when Eledon Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELDN alertsAbout Jon Kuwahara
Jon Kuwahara is recorded as CEO at Eledon Pharmaceuticals, Inc. (ELDN) since September 4, 2020. The proxy statement of Eledon Pharmaceuticals, Inc. reports total compensation of $1,218,294 for Jon Kuwahara in fiscal 2020, including a base salary of $318,951. Eledon Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Eledon Pharmaceuticals, Inc. includes David-Alexandre "DA" C. Gros, M.D. (CEO and Board Member), David-Alexandre C. Gros (CEO and Board Member), David-Alexandre C. Gros, M.D. (CEO and Board Member) and 7 others.
Affiliation history
-
Current
2020-09-04–present
-
Eledon Pharmaceuticals, Inc. (ELDN)
Proxy statement
Start not stated–2021-04-29
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Eledon Pharmaceuticals, Inc.
- David-Alexandre "DA" C. Gros, M.D. CEO, Board Member
- David-Alexandre C. Gros CEO, Board Member
- David-Alexandre C. Gros, M.D. CEO, Board Member
- David-Alexandre Gros CEO, Board Member
- Paul Little CFO, Chief Accounting Officer
- Bryan Smith General Counsel
- Allan D. Kirk Board Member
- Allan Douglas Kirk, MD, PhD, FACS Board Member
- James Robinson Board Member
- Jan Hillson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Eledon Pharmaceuticals, Inc. (ELDN) | — | $318,951 | $1,218,294 |
Recent activity
No call appearances or filed executive changes recorded yet.